First synthesis of N-[(aziridin-2-yl)methyl]benzimidazolequinone and analysis of toxicity towards normal and Fanconi anemia cells

Chemical Communications

Volumn , Issue 43, 2008, Pages 5592-5594

  O'Donovan, Liz ^a   Carty, Michael P ^a   Aldabbagh, Fawaz ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FANCONI ANEMIA GROUP D2 PROTEIN; MITOMYCIN C; N [(1 TRITYLAZIRIDIN YL)METHYL] 1H BENZIMIDAZOLE 4,7 DIONE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DEMETHYLATION; DRUG SENSITIVITY; DRUG SYNTHESIS; FANCONI ANEMIA; FIBROBLAST; HUMAN; HUMAN CELL; OXIDATION; PROTEIN EXPRESSION;

EID: 55849149810     PISSN: 13597345     EISSN: None     Source Type: Journal    
DOI: 10.1039/b814706j     Document Type: Article

References (38)

1. S. R. Rajski R. M. Williams Chem. Rev. 1998 98 2723
2. S. E. Wolkenberg D. L. Boger Chem. Rev. 2002 102 2477
3. M. Jaffar N. Abou-Zeid L. Bai I. Mrema I. Robinson R. Tanner I. J. Stratford Curr. Drug Delivery 2004 1 345
4. M. A. Colucci C. J. Moody G. D. Couch Org. Biomol. Chem. 2008 6 637
5. W. A. Remers, in Anticancer Agents from Natural Products, ed., G. M. Cragg,,, D. G. I. Kingston, and, D. J. Newman,, Taylor & Francis, Boca Raton, FL, USA, 2005, ch. 23, pp. 475-497
6. P. A. S. Lowden, in Aziridines and Epoxides in Organic Synthesis, ed., A. K. Yudin,, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2006, pp. 399-442
7. M. Tomasz A. K. Chawla R. Lipman Biochemistry 1988 27 3182
8. E. B. Skibo I. Islam W. G. Schulz R. Zhou L. Bess R. Boruah Synlett 1996 297
9. A. Suleman E. B. Skibo J. Med. Chem. 2002 45 1211
10. K. Fahey F. Aldabbagh Tetrahedron Lett. 2008 49 5235
11. C. M. Ahn S. K. Kim J. L. Han Arch. Pharmacal Res. 1998 21 599
12. I. Antonini F. Claudi G. Cristalli P. Franchetti M. Grifantini S. Martelli J. Med. Chem. 1988 31 260
13. W. G. Schulz E. B. Skibo J. Med. Chem. 2000 43 629
14. A. K. Singh J. W. Lown Anti-Cancer Drug Des. 2000 15 265
15. C. Flader J. Liu R. F. Borch J. Med. Chem. 2000 43 3157
16. L. Garuti M. Roberti M. Malagoli T. Rossi M. Castelli Bioorg. Med. Chem. Lett. 2000 10 2193
17. F. Alvarez A. Ghérardi P. Nebois M.-E. Sarciron A.-F. Pétavy N. Walchshofer Bioorg. Med. Chem. Lett. 2002 12 977
18. K.-H. Chung S.-Y. Hong H.-J. You R.-E. Park C.-K. Ryu Bioorg. Med. Chem. Lett. 2006 14 5795
19. J. J. Newsome M. A. Colucci M. Hassani H. D. Beall C. J. Moody Org. Biomol. Chem. 2007 5 3665
20. J. O'Shaughnessy D. Cunningham P. Kavanagh D. Leech P. McArdle F. Aldabbagh Synlett 2004 2382
21. J. O'Shaughnessy F. Aldabbagh Synthesis 2005 1069
22. M. Lynch S. Hehir P. Kavanagh D. Leech J. O'Shaughnessy M. P. Carty F. Aldabbagh Chem.-Eur. J. 2007 13 3218
23. S. Hehir L. O'Donovan M. P. Carty F. Aldabbagh Tetrahedron 2008 64 4196
24. C. J. Moody C. L. Norton A. M. Z. Slawin S. Taylor Anti-Cancer Drug Des. 1998 13 611
25. A. D. Auerbach S. R. Wolman Nature 1976 261 494
26. M. D. Tischkowitz S. V. Hodgson J. Med. Genet. 2003 40 1
27. L. J. Niedernhofer A. S. Lalai J. H. J. Hoeijmakers Cell (Cambridge, MA, U. S.) 2005 123 1191
28. T. Taniguchi A. D. D'Andrea Blood 2006 107 4223
29. X. Wang P. R. Andreassen A. D. D'Andrea Mol. Cell. Biol. 2004 24 5850
30. J. E. Baldwin A. C. Spivey C. J. Schofield J. B. Sweeney Tetrahedron 1993 49 6309
31. E. Kuyl-Yeheskiely M. Lodder G. A. van der Marel J. H. van Boom Tetrahedron Lett. 1992 33 3013
32. I. Utsunomiya M. Fuji T. Sato M. Natsume Chem. Pharm. Bull. 1993 41 854
33. G. A. Molander P. J. Stengel Tetrahedron 1997 53 8887
34. L. Weinberger A. R. Day J. Org. Chem. 1959 24 1451
35. H. Tohma H. Morioka Y. Harayama M. Hashizume Y. Kita Tetrahedron Lett. 2001 42 6899
36. D. W. Kim H. Y. Choi K.-J. Lee D. Y. Chi Org. Lett. 2001 3 445
37. J. Song S. Jeong S.-W. Ham J. Korean Chem. Soc. 2002 46 402
38. T. Mosmann J. Immunol. Methods 1983 65 55